HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 86 filers reported holding HARPOON THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $26,741 | -32.1% | 37,663 | -28.9% | 0.00% | – |
| Q1 2023 | $39,404 | +2.5% | 52,947 | -0.1% | 0.00% | – |
| Q4 2022 | $38,457 | -26.0% | 52,992 | 0.0% | 0.00% | – |
| Q3 2022 | $52,000 | -48.5% | 52,992 | 0.0% | 0.00% | – |
| Q2 2022 | $101,000 | -89.0% | 52,992 | -71.3% | 0.00% | – |
| Q1 2022 | $916,000 | -36.5% | 184,362 | -3.6% | 0.00% | – |
| Q4 2021 | $1,443,000 | -7.8% | 191,251 | -3.4% | 0.00% | – |
| Q3 2021 | $1,565,000 | -46.1% | 198,059 | -5.4% | 0.00% | -100.0% |
| Q2 2021 | $2,904,000 | -22.3% | 209,369 | +17.2% | 0.00% | 0.0% |
| Q1 2021 | $3,739,000 | +42.9% | 178,712 | +13.4% | 0.00% | 0.0% |
| Q4 2020 | $2,617,000 | -5.8% | 157,576 | -3.6% | 0.00% | 0.0% |
| Q3 2020 | $2,778,000 | +10.0% | 163,446 | +7.5% | 0.00% | 0.0% |
| Q2 2020 | $2,525,000 | +141.9% | 152,055 | +68.4% | 0.00% | – |
| Q1 2020 | $1,044,000 | -12.4% | 90,278 | +12.0% | 0.00% | – |
| Q4 2019 | $1,192,000 | +1.6% | 80,592 | -6.1% | 0.00% | – |
| Q3 2019 | $1,173,000 | +152.3% | 85,839 | +140.1% | 0.00% | – |
| Q2 2019 | $465,000 | +50.5% | 35,745 | +9.4% | 0.00% | – |
| Q1 2019 | $309,000 | – | 32,673 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |